Jpmorgan Chase & CO Bristol Myers Squibb CO Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 88,814,123 shares of BMY stock, worth $3.91 Billion. This represents 0.44% of its overall portfolio holdings.
Number of Shares
88,814,123
Previous 90,048,274
1.37%
Holding current value
$3.91 Billion
Previous $4.62 Billion
4.24%
% of portfolio
0.44%
Previous 0.48%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$8.19 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$7.16 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.03 Billion0.23% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.09 Billion0.79% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA53.7MShares$2.37 Billion0.68% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $93.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...